Browse by author
Lookup NU author(s): Dr Clifford Lawrence
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
An increasing number of patients who require surgical treatment for skin tumours also take anticoagulants or anti-platelet drugs to prevent thromboembolic events. Stopping therapy places the patient at risk from a thromboembolic event, whilst continuing treatment places them at risk from bleeding complications during surgery. We have reviewed all of the published studies of the effects of warfarin, aspirin, non-steroidal anti-inflammatory and other anti-platelet drugs on surgical outcome in patients having skin surgical procedures. There is little evidence that continuing with treatment is harmful in any of these groups with the exception of warfarin therapy, where the risk of haemorrhagic complications is presumably dependent on the degree of anticoagulation.
Author(s): Stables G, Lawrence CM
Publication type: Review
Publication status: Published
Journal: Clinical and Experimental Dermatology
ISSN (print): 0307-6938
ISSN (electronic): 1365-2230